Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease
- PMID: 12915459
- DOI: 10.1093/hmg/ddg265
Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease
Abstract
Transgenic Drosophila expressing human alpha-synuclein faithfully replicate essential features of human Parkinson's disease, including age-dependent loss of dopaminergic neurons, Lewy-body-like inclusions and locomotor impairment. To define the transcriptional program encoding molecular machinery involved in alpha-synuclein pathology, we characterized expression of the entire Drosophila genome at pre-symptomatic, early and advanced disease stages. Fifty-one signature transcripts, including lipid, energy and membrane transport mRNAs, were tightly associated with alpha-synuclein expression. Most importantly, at the pre-symptomatic stage, when the potential for neuroprotection is greatest, expression changes revealed specific pathology. In age-matched tau transgenic Drosophila, the transcription of alpha-synuclein associated genes was normal, suggesting highly distinct pathways of neurodegeneration. Temporal profiling of progressive gene expression changes in neurodegenerative disease models provides unbiased starting points for defining disease mechanisms and for identifying potential targets for neuroprotective drugs at pre-clinical stages.
Similar articles
-
A Drosophila model of Parkinson's disease.Nature. 2000 Mar 23;404(6776):394-8. doi: 10.1038/35006074. Nature. 2000. PMID: 10746727
-
Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.Science. 2002 Feb 1;295(5556):865-8. doi: 10.1126/science.1067389. Epub 2001 Dec 20. Science. 2002. PMID: 11823645
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.Neuron. 2006 Oct 5;52(1):33-8. doi: 10.1016/j.neuron.2006.09.026. Neuron. 2006. PMID: 17015225 Review.
-
Synucleins and their relationship to Parkinson's disease.Cell Tissue Res. 2004 Oct;318(1):163-74. doi: 10.1007/s00441-004-0921-7. Epub 2004 Jul 24. Cell Tissue Res. 2004. PMID: 15503152 Review.
Cited by
-
SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity.Toxicol Sci. 2010 Dec;118(2):613-24. doi: 10.1093/toxsci/kfq285. Epub 2010 Sep 20. Toxicol Sci. 2010. PMID: 20855423 Free PMC article.
-
Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.BMC Neurosci. 2004 Apr 16;5:14. doi: 10.1186/1471-2202-5-14. BMC Neurosci. 2004. PMID: 15090075 Free PMC article.
-
Recent advances in using Drosophila to model neurodegenerative diseases.Apoptosis. 2009 Aug;14(8):1008-20. doi: 10.1007/s10495-009-0347-5. Apoptosis. 2009. PMID: 19373559 Free PMC article. Review.
-
The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response.Mol Cell Biochem. 2009 Jun;326(1-2):55-66. doi: 10.1007/s11010-008-0008-y. Epub 2008 Dec 31. Mol Cell Biochem. 2009. PMID: 19116775
-
α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies.Parkinsons Dis. 2010 Dec 20;2011:212706. doi: 10.4061/2011/212706. Parkinsons Dis. 2010. PMID: 21209707 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
